One_CD
gene_NN
,_,
two_CD
transcripts_NNS
:_:
isolation_NN
of_IN
an_DT
alternative_JJ
transcript_NN
encoding_VBG
for_IN
the_DT
autoantigen_NN
La\/SS-B_NN
from_IN
a_DT
cDNA_NN
library_NN
of_IN
a_DT
patient_NN
with_IN
primary_JJ
Sjogrens_NN
'_POS
syndrome_NN
._.

A_DT
cDNA_NN
library_NN
was_VBD
prepared_VBN
from_IN
peripheral_JJ
blood_NN
lymphocytes_NNS
of_IN
an_DT
autoimmune_JJ
patient_NN
with_IN
primary_JJ
Sjogrens_NN
'_POS
syndrome_NN
._.

The_DT
cDNA_NN
library_NN
was_VBD
screened_VBN
with_IN
the_DT
patients_NNS
own_JJ
autoimmune_JJ
serum_NN
being_VBG
monospecific_JJ
for_IN
the_DT
nuclear_JJ
autoantigen_NN
La\/SS-B_NN
._.

Thereby_RB
an_DT
alternative_JJ
type_NN
of_IN
La_NN
mRNA_NN
was_VBD
identified_VBN
that_IN
differed_VBD
from_IN
the_DT
known_JJ
La_NN
mRNA_NN
due_JJ
to_TO
an_DT
exchange_NN
of_IN
the_DT
exon_NN
1_CD
._.

Sequencing_NN
of_IN
the_DT
genomic_JJ
region_NN
between_IN
the_DT
exons_NNS
1_CD
and_CC
2_CD
showed_VBD
that_IN
the_DT
alternative_JJ
5_CD
'_NN
-_:
end_NN
is_VBZ
a_DT
part_NN
of_IN
the_DT
intron_NN
._.

In_IN
addition_NN
,_,
the_DT
presence_NN
of_IN
an_DT
alternative_JJ
promoter_NN
site_NN
,_,
which_WDT
exists_VBZ
within_IN
the_DT
intron_NN
downstream_JJ
of_IN
the_DT
exon_NN
1_CD
,_,
became_VBD
evident_JJ
._.

In_IN
consequence_NN
,_,
the_DT
alternative_JJ
La_NN
mRNA_NN
is_VBZ
the_DT
result_NN
of_IN
a_DT
promoter_NN
switching_NN
combined_VBN
with_IN
an_DT
alternative_JJ
splicing_NN
mechanism_NN
._.

In_IN
the_DT
intron_NN
,_,
further_JJ
transcription_NN
factor_NN
binding_NN
sites_NNS
,_,
including_VBG
a_DT
NF-kappa_NN
B_NN
element_NN
,_,
were_VBD
identified_VBN
leading_VBG
to_TO
the_DT
suggestion_NN
that_IN
the_DT
expression_NN
of_IN
the_DT
gene_NN
encoding_VBG
for_IN
the_DT
nuclear_JJ
autoantigen_NN
La\/SS-B_NN
alters_VBZ
in_IN
dependence_NN
on_IN
disease_NN
conditions_NNS
._.

